drug_analysis.exe
SCIENTIFIC_DATA

TIRZEPATIDE:
THE_REAL_DRUG

Tirzepatide is the active ingredient in branded medications like Mounjaro® and Zepbound®. Here's the technical breakdown.

COMPOUND_OVERVIEW

tirzepatide.dat

Tirzepatide is a DUAL GLP-1 AND GIP RECEPTOR AGONIST - the first of its kind. It was developed by Eli Lilly and represents a significant advancement in weight loss medication.

> GLP-1_ACTION

Slows gastric emptying, reduces appetite, and improves insulin sensitivity. Similar mechanism to semaglutide (Ozempic/Wegovy).

> GIP_ACTION

Additional metabolic benefits, enhanced insulin release, and potentially better weight loss outcomes vs GLP-1 alone.

> RESULT: Dual mechanism enables significantly greater weight loss in published clinical research - more than any single GLP-1 agonist alone.

BRAND_NAME_ANALYSIS

BRAND_NAME ACTIVE_INGREDIENT APPROVED_USE NIGERIA_STATUS
Mounjaro Tirzepatide Type 2 Diabetes (US) NOT_AVAILABLE
Zepbound Tirzepatide Weight Loss (US) NOT_AVAILABLE
Compounded Tirzepatide Weight Loss AVAILABLE

KEY_POINT:

Tirzepatide is the ACTIVE INGREDIENT in branded medications like Mounjaro® and Zepbound®. Compounded tirzepatide contains the same active pharmaceutical ingredient.

CLINICAL_TRIAL_DATA

> These results are for tirzepatide - the molecule - regardless of brand name.

SIG.
WEIGHT_LOSS
@ highest dose
PUBLISHED_DATA
72
WEEKS_SUSTAINED
long-term efficacy
VERIFIED
52%
LOST_20%+
@ 15mg dose
PUBLISHED_DATA

> IMPORTANT: These results come from the molecule tirzepatide, not from any specific brand. Compounded tirzepatide contains the same active ingredient.

MECHANISM_OF_ACTION

01

APPETITE_REDUCTION

Acts on brain receptors to decrease hunger signals. You feel satisfied with less food, making it easier to maintain a caloric deficit.

02

DIGESTION_DELAY

Delays gastric emptying so food stays in your stomach longer. This extends feelings of fullness after meals.

03

INSULIN_OPTIMIZATION

Enhances your body's response to insulin, helping regulate blood sugar and reduce fat storage. The dual GIP action provides additional metabolic benefits.

04

WEEKLY_INJECTION

One subcutaneous injection per week. Doses start low (2.5mg) and gradually increase to minimize side effects. Maximum dose is 15mg weekly.

DOSING_PROTOCOL

5mg
STARTING_DOSE
10mg
MEDIUM_DOSE
15mg
MAXIMUM_DOSE

> Doses are increased gradually over weeks to minimize side effects.
> Your healthcare provider will determine the right titration schedule.

> READY_TO_START:

GET REAL TIRZEPATIDE

Pharmaceutical-grade tirzepatide at fair prices. No fake "Mounjaro" labels, just the real drug with proper cold-chain delivery.

[EXECUTE: GET_TIRZEPATIDE]